A Day Up For Constellation Pharmaceuticals, Inc.
Wed, Jun 02, 2021 at 05:30 PM
Constellation Pharmaceuticals, Inc. (CNST:NASDAQ) shot up at $33.57, representing a gain of 65.9%. The stock got featured on our News Catalysts scanner on Wed, Jun 02, 2021 at 05:23 PM in the 'ACQUISITION' category. From Tue, May 18, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Constellation Pharmaceuticals, Inc. (CNST:NASDAQ)
Constellation Pharmaceuticals Inc is a clinical-stage biopharmaceutical company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.
Top 10 Gainers:
- AMC Entertainment Holdings, Inc. (AMC:NYSE), 95.22%
- BCTX (BCTX:NASDAQ), 94.34%
- Koss Corporation (KOSS:NASDAQ), 68.61%
- Constellation Pharmaceuticals, Inc. (CNST:NASDAQ), 65.86%
- Bed Bath & Beyond Inc. (BBBY:NASDAQ), 62.11%
- PetMed Express, Inc. (PETS:NASDAQ), 58.39%
- GTT Communications, Inc. (GTT:NYSE), 57.23%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 42.85%
- Express, Inc. (EXPR:NYSE), 36.48%
- AHLD (AHLD:NYSE), 34.81%